Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan
MT Newswires Live
Sep 03
Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.
The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.
Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.
After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.